Evidence map›Paper›PMID 26066539›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2016

Clinical phenotype of the recurrent 1q21.1 copy-number variant.

Raphael Bernier, Kyle J Steinman, Beau Reilly, Arianne Stevens Wallace, Elliott H Sherr, Nicholas Pojman, Heather C Mefford, Jennifer Gerdts, Rachel Earl, Ellen Hanson and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed, 1 pooled it
17.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 1 synthesis or guideline pooled it, 195 citations in OpenAlex.

  1. Autism spectrum disorder and schizophrenia: An updated conceptual review.Autism research : official journal of the International Society for Autism Research · 2022
    Pooled it
  2. Article
  3. Review
  4. Human reproduction open · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Human Genetics of Congenital Heart Defects.Advances in experimental medicine and biology · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 10 institutions in 1 country.

Raphael BernierDepartment of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, USA.
Kyle J SteinmanDepartment of Neurology, University of Washington, Seattle, Washington, USA.
Beau ReillyLakeside Center for Autism, Issaquah, Washington, USA.
Arianne Stevens WallaceDepartment of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, USA.
Elliott H SherrDepartment of Neurology, University of California San Francisco, San Francisco, California, USA.
Nicholas PojmanDepartment of Neurology, University of California San Francisco, San Francisco, California, USA.
Heather C MeffordDepartment of Pediatrics, University of Washington, Seattle, Washington, USA.
Jennifer GerdtsDepartment of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, USA.
Rachel EarlDepartment of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, USA.
Ellen HansonDivision of Developmental Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
Robin P Goin-KochelDepartment of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
Leandra BerryDepartment of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
Stephen KanneThompson Autism Center, University of Missouri, Columbia, Missouri, USA.
LeeAnne Green SnyderDivision of Developmental Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
Sarah SpenceDepartment of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.
Melissa B RamockiDepartment of Neurology, Texas Children's Hospital, Houston, Texas, USA.
David W EvansAutism & Developmental Medicine Institute, Danville, Pennsylvania, USA.
John E SpiroSimons Foundation, New York, New York, USA.
Christa L MartinAutism & Developmental Medicine Institute, Danville, Pennsylvania, USA.
David H LedbetterAutism & Developmental Medicine Institute, Danville, Pennsylvania, USA.ORCID http://orcid.org/0000-0001-8934-4210
Wendy K ChungDepartment of Pediatrics, Columbia University, New York, New York, USA.ORCID http://orcid.org/0000-0003-3438-5685
Simons VIP consortium
University of Washington · USAutism & Developmental Medicine Institute · USBoston Children's Hospital · USBaylor College of Medicine · USUniversity of California, San Francisco · USCenter for Autism and Related Disorders · USColumbia University · USSimons Foundation · USTexas Children's Hospital · USUniversity of Missouri · US

Funding

GENE DOSAGE IMBALANCE IN NEURODEVELOPMENTAL DISORDERSR01MH074090 · NIMH · GEISINGER CLINIC · PI David H. Ledbetter, CHRISTA LESE MARTIN · 2005 to 2026
$13.5M
NIMH NIH HHS MH074090NIMH NIH HHS R01 MH074090
6 · The paper itself

Abstract

purposeTo characterize the clinical phenotype of the recurrent copy-number variation (CNV) at 1q21.1, we assessed the psychiatric and medical phenotypes of 1q21.1 deletion and duplication carriers ascertained through clinical genetic testing and family member cascade testing, with particular emphasis on dimensional assessment across multiple functional domains.

methodsNineteen individuals with 1q21.1 deletion, 19 individuals with the duplication, and 23 familial controls (noncarrier siblings and parents) spanning early childhood through adulthood were evaluated for psychiatric, neurologic, and other medical diagnoses, and their cognitive, adaptive, language, motor, and neurologic domains were also assessed. Twenty-eight individuals with 1q21.1 CNVs (15 deletion, 13 duplication) underwent structural magnetic resonance brain imaging.

resultsProbands with 1q21.1 CNVs presented with a range of psychiatric, neurologic, and medical disorders. Deletion and duplication carriers shared several features, including borderline cognitive functioning, impaired fine and gross motor functioning, articulation abnormalities, and hypotonia. Increased frequency of Autism Spectrum Disorder (ASD) diagnosis, increased ASD symptom severity, and increased prevalence of macrocephaly were observed in the duplication relative to deletion carriers, whereas reciprocally increased prevalence of microcephaly was observed in the deletion carriers.

conclusionsIndividuals with 1q21.1 deletions or duplications exhibit consistent deficits on motor and cognitive functioning and abnormalities in head circumference.Genet Med 18 4, 341-349.

Indexed as

Chromosomes, Human, Pair 1DNA Copy Number VariationsPhenotypeAdultChildChild, PreschoolChromosome DeletionChromosome DisordersChromosome DuplicationFemaleHumansMaleMiddle AgedNeuropsychological TestsRegistriesYoung Adult

Identifiers

PMID26066539
PMCPMC7263044
OpenAlexW2176255924

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.